Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis.

OBJECTIVE--To evaluate the efficacy of high-dose verapamil treatment (240 mg twice daily) in the prevention of angiographic restenosis after primary successful coronary angioplasty in patients at high risk of recurrent obstruction. DESIGN--A placebo controlled, double blind trial in which patients w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br Heart J
Main Authors: Hoberg, E., Dietz, R., Frees, U., Katus, H. A., Rauch, B., Schömig, A., Schuler, G., Schwarz, F., Tillmanns, H., Niebauer, J.
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 1994
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC483663/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8142195/
https://ncbi.nlm.nih.govhttps://doi.org/10.1136/hrt.71.3.254
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados